Growing Market Presence Microba Life Sciences has recently secured significant funding of $14.5 million and a strategic investment of $17.8 million, demonstrating strong investor confidence and positioning for scalable growth in microbiome testing and therapeutics, which can open opportunities for sales of testing kits, platform licenses, or strategic partnerships.
Product Expansion Opportunities The launch of innovative products such as MetaPanel and successful clinical trials of MAP 315 indicate ongoing R&D progress, suggesting potential avenues for healthcare providers and pharma companies to adopt or collaborate on advanced microbiome-based diagnostics and treatments.
Market Penetration Through Partnerships Partnerships with major industry players like Sonic Healthcare and collaborations with contract manufacturers like Bacthera highlight a proactive approach to distribution and large-scale production, presenting opportunities for business development in distribution agreements, OEM collaborations, or clinical services.
Focus on Clinical Validation Microba’s emphasis on clinical-grade testing and successful Phase 1 clinical trials of MAP 315 suggest credibility in scientific validation, making the company an appealing partner for healthcare institutions, research organizations, and pharmaceutical companies seeking validated microbiome solutions.
Technology and Data Insights Utilizing advanced tech stacks like Python, NoSQL, and SEO tools, Microba is positioned to leverage data-driven approaches for personalized health insights, indicating potential for innovative sales opportunities in health analytics, data services, and scalable microbiome diagnostics targeted at practitioners and health plans.
$10M$25M
$25M$50M
$50M$100M
$10M$25M
$1M$10M
$1M$10M
$1MMicroba Life Sciences uses 8 technology products and services including NoSQL, git, Font Awesome, and more. Explore Microba Life Sciences's tech stack below.
| Microba Life Sciences Email Formats | Percentage |
| First.Last@microba.com | 49% |
| First.Middle@microba.com | 1% |
| First.Last@microba.com | 49% |
| First.Middle@microba.com | 1% |
Health and Human ServicesQueensland, Australia51-200 Employees
Clinical-grade microbiome testing that gives practitioners confidence and helps people live healthier, happier lives. Better science. Better insights. Better health. Microba. Expect better.
Company Overview
Media & News
Funding & FinancialsMicroba Life Sciences has raised a total of $12M of funding over 4 rounds. Their latest funding round was raised on Nov 28, 2022 in the amount of $12M.
Microba Life Sciences's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsMicroba Life Sciences has raised a total of $12M of funding over 4 rounds. Their latest funding round was raised on Nov 28, 2022 in the amount of $12M.
Microba Life Sciences's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com